BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19086012)

  • 1. Proton MRS of the breast in the clinical setting.
    Mountford C; Ramadan S; Stanwell P; Malycha P
    NMR Biomed; 2009 Jan; 22(1):54-64. PubMed ID: 19086012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of breast cancer using two-dimensional MRS.
    Thomas MA; Lipnick S; Velan SS; Liu X; Banakar S; Binesh N; Ramadan S; Ambrosio A; Raylman RR; Sayre J; DeBruhl N; Bassett L
    NMR Biomed; 2009 Jan; 22(1):77-91. PubMed ID: 19086016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton magnetic resonance spectroscopy of tubercular breast abscess: report of a case.
    Das CJ; Medhi K
    J Comput Assist Tomogr; 2008; 32(4):599-601. PubMed ID: 18664848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo proton magnetic resonance spectroscopy of breast lesions: an update.
    Tse GM; Yeung DK; King AD; Cheung HS; Yang WT
    Breast Cancer Res Treat; 2007 Sep; 104(3):249-55. PubMed ID: 17051424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton spectroscopy provides accurate pathology on biopsy and in vivo.
    Mountford C; Lean C; Malycha P; Russell P
    J Magn Reson Imaging; 2006 Sep; 24(3):459-77. PubMed ID: 16897689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative multivoxel proton chemical shift imaging of the breast.
    Sijens PE; Dorrius MD; Kappert P; Baron P; Pijnappel RM; Oudkerk M
    Magn Reson Imaging; 2010 Apr; 28(3):314-9. PubMed ID: 20071119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Needle aspiration cytology of the breast: current perspective on the role in diagnosis and management].
    Kocjan G
    Acta Med Croatica; 2008 Oct; 62(4):391-401. PubMed ID: 19205416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine-needle aspirates analysed using a statistical classification strategy.
    Mountford CE; Somorjai RL; Malycha P; Gluch L; Lean C; Russell P; Barraclough B; Gillett D; Himmelreich U; Dolenko B; Nikulin AE; Smith IC
    Br J Surg; 2001 Sep; 88(9):1234-40. PubMed ID: 11531873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo proton MR spectroscopy of the breast.
    Stanwell P; Mountford C
    Radiographics; 2007 Oct; 27 Suppl 1():S253-66. PubMed ID: 18180231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo magnetic resonance spectroscopy of gynaecological tumours at 3.0 Tesla.
    Booth SJ; Pickles MD; Turnbull LW
    BJOG; 2009 Jan; 116(2):300-3. PubMed ID: 19076962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton magnetic resonance spectroscopy in neuroblastoma: current status, prospects and limitations.
    Lindskog M; Spenger C; Klason T; Jarvet J; Gräslund A; Johnsen JI; Ponthan F; Douglas L; Nordell B; Kogner P
    Cancer Lett; 2005 Oct; 228(1-2):247-55. PubMed ID: 15946794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exponential convergence rate (the spectral convergence) of the fast Padé transform for exact quantification in magnetic resonance spectroscopy.
    Belkić D
    Phys Med Biol; 2006 Dec; 51(24):6483-512. PubMed ID: 17148831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton MR spectroscopy of the breast.
    Tozaki M
    Breast Cancer; 2008; 15(3):218-23. PubMed ID: 18443899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
    Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
    J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
    Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
    Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proton magnetic resonance spectroscopy in the diagnosis of breast cancer].
    Meladze NV; Kuchuk PV; Abduraimov AB; Les'ko KA; Shariia MA; Malik DS; Matkhev S; Boĭko EA
    Vestn Rentgenol Radiol; 2011; (4):31-6. PubMed ID: 22288145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desmoid tumor of the breast: the role of proton magnetic resonance spectroscopy for a benign breast lesion mimicking a malignancy.
    Okamoto K; Kurihara Y; Imamura K; Kanemaki Y; Nakajima Y; Fukuda M; Maeda I
    Breast J; 2008; 14(4):376-8. PubMed ID: 18687071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of grade and receptor status from the primary breast lesion by magnetic resonance spectroscopy.
    Lean C; Doran S; Somorjai RL; Malycha P; Clarke D; Himmelreich U; Bourne R; Dolenko B; Nikulin AE; Mountford C
    Technol Cancer Res Treat; 2004 Dec; 3(6):551-6. PubMed ID: 15560712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possibilities for improved early breast cancer detection by Padé-optimized magnetic resonance spectroscopy.
    Belkić K; Belkić D
    Isr Med Assoc J; 2011 Apr; 13(4):236-43. PubMed ID: 21598814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential use of in vivo proton spectroscopy for head and neck lesions.
    Mafee MF; Bárány M; Gotsis ED; Dobben GD; Puklin J; Chow JM; Wenig BL
    Radiol Clin North Am; 1989 Mar; 27(2):243-54. PubMed ID: 2537499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.